Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-06-30 Purchase |
2020-07-02 4:16 pm |
Akouos Inc. | AKUS | Novartis Bioventures Ltd NOVARTIS AG Former 10% Owner |
125,000 | $17 | $2,125,000 | 1,181,258 (Indirect) |
View |
| 2020-06-18 Sale |
2020-06-22 4:52 pm |
Galera Therapeutics Inc. | GRTX | Novartis Bioventures Ltd NOVARTIS AG Former 10% Owner |
1,002,212 | $8.2507 | $8,268,960 | 2,467,961 (Direct) |
View |
| 2020-06-15 Sale |
2020-06-17 5:47 pm |
Galera Therapeutics Inc. | GRTX | Novartis Bioventures Ltd NOVARTIS AG 10% Owner |
19,386 | $9.2134 | $178,610 | 3,470,173 (Direct) |
View |
| 2020-06-10 Sale |
2020-06-12 6:33 pm |
Galera Therapeutics Inc. | GRTX | Novartis Bioventures Ltd NOVARTIS AG 10% Owner |
17,232 | $9.332 | $160,810 | 3,489,559 (Direct) |
View |
| 2020-06-05 Sale |
2020-06-09 8:02 pm |
Galera Therapeutics Inc. | GRTX | Novartis Bioventures Ltd NOVARTIS AG 10% Owner |
21,311 | $9.568 | $203,904 | 3,506,791 (Direct) |
View |
| 2020-06-02 Sale |
2020-06-04 5:36 pm |
Galera Therapeutics Inc. | GRTX | Novartis Bioventures Ltd NOVARTIS AG 10% Owner |
14,965 | $9.6793 | $144,851 | 3,528,102 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2022-06-27 4:38 pm |
N/A N/A |
PRECISION BIOSCIENCES INC | DTIL | NOVARTIS PHARMA AG NOVARTIS AG 10% Owner |
0 | $0 | 12,407,440 (Direct) |
View |
Ownership |
2020-08-14 4:32 pm |
N/A N/A |
Cellular Biomedicine Group Inc. | CBMG | NOVARTIS PHARMA AG NOVARTIS AG 10% Owner |
0 | $0 | 1,458,257 (Direct) |
View |
| 2020-07-14 Conversion |
2020-07-16 4:53 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | NOVARTIS PHARMA AG NOVARTIS AG 10% Owner |
13,275,476 | $0 | 5,908,089 (Direct) |
View |
Ownership |
2020-07-13 06:02 am |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | NOVARTIS PHARMA AG NOVARTIS AG 10% Owner |
0 | $0 | 5,908,089 (Direct) |
View |
| 2020-06-30 Conversion |
2020-07-02 4:16 pm |
N/A N/A |
Akouos Inc. | AKUS | Novartis Bioventures Ltd NOVARTIS AG Former 10% Owner |
1,056,258 | $0 | 1,181,258 (Indirect) |
View |
Ownership |
2020-06-25 7:15 pm |
N/A N/A |
Akouos Inc. | AKUS | Novartis Bioventures Ltd NOVARTIS AG 10% Owner |
0 | $0 | 1,056,258 (Indirect) |
View |
Ownership |
2020-06-18 9:16 pm |
N/A N/A |
Forma Therapeutics Holdings Inc. | FMTX | Novartis Bioventures Ltd NOVARTIS AG 10% Owner |
0 | $0 | 2,991,705 (Indirect) |
View |